RAFAEL BAÑARES CAÑIZARES-rekin lankidetzan egindako argitalpenak (67)

2024

  1. Demographic Trends in Liver Transplant Survivors after 3 Decades of Program Implementation: The Impact of Cohort and Period Effects on Life Expectancy

    Transplantation Direct, Vol. 10, Núm. 8, pp. e1684

  2. Hepatic hemodynamic study: More than just HVPG measurement

    Gastroenterologia y Hepatologia

  3. Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure

    Hepatology

  4. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure

    Journal of Hepatology, Vol. 81, Núm. 1, pp. 76-83

2023

  1. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma

    JHEP Reports, Vol. 5, Núm. 3

  2. Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study

    Therapeutic Advances in Gastroenterology, Vol. 16

  3. Prognostic implications of systolic function in patients with cirrhosis

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 446-454

2022

  1. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study

    European Journal of Neurology, Vol. 29, Núm. 2, pp. 400-412

  2. Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history

    United European Gastroenterology Journal, Vol. 10, Núm. 8, pp. 805-816

2021

  1. HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation

    Transplant International, Vol. 34, Núm. 11, pp. 2214-2225

  2. Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients

    Therapeutic Advances in Gastroenterology, Vol. 14

2020

  1. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

    Hepatology, Vol. 72, Núm. 6, pp. 1924-1934

  2. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients

    Liver International, Vol. 40, Núm. 9, pp. 2215-2227

  3. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort

    Journal of Hepatology, Vol. 72, Núm. 4, pp. 702-710

2019

  1. Advances in health and disease: Paracentesis in medicine

    Advances in Health and Disease (Nova Science Publishers, Inc.), pp. 1-52

  2. Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients

    Liver Transplantation, Vol. 25, Núm. 8, pp. 1177-1186

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

2017

  1. Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

    Journal of Hepatology, Vol. 66, Núm. 6, pp. 1138-1148

  2. Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis

    Hepatology, Vol. 65, Núm. 6, pp. 2019-2030